The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro And Exercise Side Effects — How It Compares To Wegovy
If you're considering Mounjaro (tirzepatide) or Wegovy (semaglutide) for weight management and wondering how these medications affect exercise, this guide compares both. Both GLP-1 receptor agonists can cause side effects that may impact physical activity, though individual experiences vary significantly. Understanding the differences between Mounjaro's dual GIP and GLP-1 mechanism versus Wegovy's single GLP-1 pathway can help you and your GP make an informed choice. This information is for general educational purposes only.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro And Wegovy Affect Exercise Performance
Nausea and stomach discomfort are the most common side effects affecting exercise with both medications. These typically occur when starting or increasing doses and may make cardiovascular activity uncomfortable. Mounjaro's dual GIP and GLP-1 action may cause slightly more initial gastrointestinal effects in some people compared to Wegovy's single GLP-1 mechanism, though clinical data shows both are generally well-tolerated. Side effects often improve within 2–4 weeks as your body adjusts.
- Nausea peaks 24–48 hours after injection
- Light exercise (walking, stretching) is usually tolerable even with mild nausea
- High-intensity exercise may be uncomfortable during acute side effects
- Staying hydrated and eating small meals can help manage symptoms
- Inform your prescriber if exercise-related side effects persist beyond 4 weeks
Both Mounjaro and Wegovy require a UK prescription following clinical assessment. Dose titration (gradual increases from 2.5 mg Mounjaro or 0.25 mg Wegovy) helps minimise initial side effects and allows your body to adapt before progressing exercise intensity.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Individual Suitability And When To Choose Which Medication
The choice between Mounjaro and Wegovy depends on your individual health profile, not just exercise considerations. Clinical trial data (SURMOUNT-1 for Mounjaro, STEP-1 for Wegovy) shows both support weight loss effectively, with average results of 15–21% and approximately clinically studied weight loss respectively. Some people tolerate Mounjaro's dual mechanism better during exercise; others prefer Wegovy's single GLP-1 action.
- Only a licensed prescriber can assess which medication suits your fitness level and health conditions
- NHS or private prescribing both require a clinical assessment before starting
- Your prescriber may recommend starting at the lowest dose and increasing gradually if exercise is important to you
- Track how you feel using our free GLP-1 weight loss calculator alongside a progress tracker to monitor both fitness and weight loss outcomes
Any concerns about medication side effects affecting your exercise routine should be discussed with your GP immediately.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I exercise while taking Mounjaro or Wegovy?
Yes, regular physical activity is encouraged with both medications. Light to moderate exercise (walking, swimming, yoga) is usually tolerable even with mild side effects. High-intensity exercise may feel uncomfortable during acute nausea, particularly in the first few weeks. Inform your GP if side effects significantly impact your ability to exercise. Most people resume normal exercise within 4 weeks as their body adjusts.
Does Mounjaro cause more exercise side effects than Wegovy?
Mounjaro's dual GIP and GLP-1 mechanism may cause slightly more initial gastrointestinal effects in some individuals compared to Wegovy's single GLP-1 action, though clinical trial data shows both are well-tolerated overall. Individual experiences vary significantly. Some people experience fewer side effects with Mounjaro; others prefer Wegovy. Your prescriber will assess which suits you best.
When should I exercise on my injection day?
Most people find light exercise (30 minutes walking) is fine on injection day (usually once weekly for both Mounjaro and Wegovy). If you experience nausea peaking 24–48 hours post-injection, consider scheduling more intense exercise for other days. There is no strict rule — listen to your body and adjust your routine based on how you feel.
Will Mounjaro or Wegovy help me lose more weight if I exercise?
Yes, combining these medications with regular physical activity and a calorie-controlled diet produces better weight loss outcomes. Both medications support appetite regulation, making it easier to maintain a reduced-calorie diet. Exercise also provides independent health benefits (cardiovascular fitness, muscle retention, mental health) beyond weight loss alone.
Which medication is better for athletes or very active people?
Neither medication is specifically formulated for athletes. If you exercise intensively, discuss this with your prescriber before starting treatment. Some very active individuals may experience fatigue as a side effect initially. Starting at the lowest dose and gradually increasing (dose titration) allows your body to adapt while maintaining your exercise routine. Individual tolerance varies significantly.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.